Clinical Trial Update: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors [Phase 2]

View source ↗

Summary

Phase 2 multicenter study evaluating pegylated liposomal doxorubicin plus carboplatin in gynecologic mesenchymal tumors, including carcinosarcoma and leiomyosar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Carcinosarcoma
• Uterine Leiomyosarcoma
• Uterine Mesenchymal Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: AGO Study Group | Conditions: Mesenchymal Tumor, Carcinosarcoma | Phase 2 | Status: COMPLETED